1. Academic Validation
  2. Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome

Impairment of the mitochondrial one-carbon metabolism enzyme SHMT2 causes a novel brain and heart developmental syndrome

  • Acta Neuropathol. 2020 Dec;140(6):971-975. doi: 10.1007/s00401-020-02223-w.
Àngels García-Cazorla 1 2 Edgard Verdura 3 4 Natalia Juliá-Palacios 5 3 Eric N Anderson 6 Leire Goicoechea 3 4 Laura Planas-Serra 3 4 Enkhtuul Tsogtbaatar 7 8 9 Nikita R Dsouza 10 Agatha Schlüter 3 4 Roser Urreizti 3 11 Jessica M Tarnowski 12 13 Ralitza H Gavrilova 12 13 SHMT2 Working Group Montserrat Ruiz 3 4 Agustí Rodríguez-Palmero 3 4 14 Stéphane Fourcade 3 4 Benjamin Cogné 15 Thomas Besnard 15 Marie Vincent 15 Stéphane Bézieau 15 Clifford D Folmes 7 8 9 Michael T Zimmermann 10 16 Eric W Klee 12 17 18 Udai Bhan Pandey 6 Rafael Artuch 3 11 Margot A Cousin 17 18 Aurora Pujol 19 20 21
Affiliations

Affiliations

  • 1 Neurometabolic Unit and Synaptic Metabolism Lab, Neurology Department, Institut Pediàtric de Recerca, Hospital Sant Joan de Déu, and MetabERN, 08950, Barcelona, Catalonia, Spain. agarcia@sjdhospitalbarcelona.org.
  • 2 Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain. agarcia@sjdhospitalbarcelona.org.
  • 3 Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
  • 4 Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain.
  • 5 Neurometabolic Unit and Synaptic Metabolism Lab, Neurology Department, Institut Pediàtric de Recerca, Hospital Sant Joan de Déu, and MetabERN, 08950, Barcelona, Catalonia, Spain.
  • 6 Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15224, USA.
  • 7 Department of Cardiovascular Medicine, Mayo Clinic, Scottdale, AZ, 85260, USA.
  • 8 Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottdale, AZ, 85260, USA.
  • 9 Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Scottdale, AZ, 85260, USA.
  • 10 Bioinformatics Research and Development Laboratory, Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
  • 11 Clinical Biochemistry Department, Institut de Recerca Sant Joan de Déu, and MetabERN, 08950, Barcelona, Catalonia, Spain.
  • 12 Department of Clinical Genomics, Mayo Clinic, Rochester, MN, 55905, USA.
  • 13 Department of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
  • 14 Department of Pediatrics, Paediatric Neurology Unit, University Hospital Germans Trias i Pujol, 08916, Badalona, Catalonia, Spain.
  • 15 Service de Génétique Médicale, CHU de Nantes, and INSERM, CNRS, Université de Nantes, l'Institut du Thorax, Nantes, 44000, Nantes, Pays de la Loire, France.
  • 16 Clinical and Translational Science Institute, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
  • 17 Center for Individualized Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
  • 18 Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
  • 19 Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain. apujol@idibell.cat.
  • 20 Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908, Barcelona, Catalonia, Spain. apujol@idibell.cat.
  • 21 Catalan Institution of Research and Advanced Studies (ICREA), 08010, Barcelona, Catalonia, Spain. apujol@idibell.cat.
Keywords

Cardiomyopathy; Congenital microcephaly; Mitochondrial one-carbon metabolism; Perisylvian polymicrogyria; SHMT2.

Figures